A Single Ascending Dose Study of AV-006 in Healthy Subjects

Clinical trial NCT03931876 · UNKNOWN

Trial details

NCT number: NCT03931876
Sponsor: Arixa Pharmaceuticals
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Bacterial Infections

Start date: 2019-06-24
Primary completion: 2019-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.